Clinical outcomes and complications associated with TORS for OSAHS: A benchmark for evaluating an emerging surgical technology in a targeted application for benign disease

Claudio Vicini, Filippo Montevecchi, Aldo Campanini, Iacopo Dallan, Paul T. Hoff, Matthew E. Spector, Erica Thaler, Jeffrey Ahn, Peter Baptista, Marc Remacle, George Lawson, Marco Benazzo, Pietro Canzi

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The aim of this study was to create benchmarks for evaluating clinical outcomes and complications of transoral robotic surgeries (TORS) in a multicenter setting. Methods: 243 TORS for obstructive sleep apnea/hypopnea syndrome (OSAHS) operations, carried out between 2008 and 2012, were analyzed at 7 different centers. The average hospitalization was 3.5 days. The mean patient age was 50 ± 12 years, the average BMI at the time of the procedure was 28.53 ± 3.87 and the majority of the patients were men (81%). Results: The mean preoperative and postoperative apnea/hypopnea index was 43.0 ± 22.6 and 17.9 ± 18.4, respectively (p <0.001). The mean preoperative and postoperative Epworth Sleepiness Scale score was 12.34 ± 5.19 and 5.7 ± 3.49, respectively (p <0.001). The mean pre-and postoperative lowest O2 saturation was 79.5 ± 8.77 and 83.9 ± 6.38%, respectively (p <0.001). Conclusions: Patients undergoing TORS as part of a multilevel approach for the treatment of OSAHS have a reasonable expectation of success with minimal long-term morbidity.

Original languageEnglish
Pages (from-to)63-69
Number of pages7
JournalORL
Volume76
Issue number2
DOIs
Publication statusPublished - 2014

Keywords

  • Complications
  • Lingual tonsillectomy
  • Obstructive sleep apnea
  • Outcomes
  • Transoral robotic surgery

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Clinical outcomes and complications associated with TORS for OSAHS: A benchmark for evaluating an emerging surgical technology in a targeted application for benign disease'. Together they form a unique fingerprint.

Cite this